Summary
During long-term pumping, the material of which driving diaphragms (DD) in total artificial hearts are constructed is subjected to many factors that limit its durability and functional capacity. Severe mechanical stress, various physical factors, temperature changes of the material, a long contact with blood, and possibly, even immune reactions between the diaphragm material and the immunological defense system of the organism must be considered.
The first reaction between the diaphragm surface and the blood components of the host organism is protein adsorption on the diaphragm surface. The procoagulant pathway is thus activated and thrombi created by this pathway grow as a primarily induced process and then become a biological skeleton for the anchoring and further growth of calcified deposits (CD). This type of calcification is dystrophic a secondary process, and it thus escapes from the regulatory processes that govern the mechanisms of calcification. At least in the initial period of pumping, experimental animals are treated with anticoagulant and antiplatelet agents. The pro-coagulant pathway may thus be more or less suppressed, becoming subsumed by the increased tendency to calcification. The protein and the phospholipid layer become a receptive field for calcifying nuclei. This process is then regulated by the specific regulatory mechanisms of calcification. Under these conditions, the thrombotization of calcified deposits is a secondary process.
The study of calciphylaxis has revealed the possibility of extending experimental calcification heterotopically to various organs and tissues. Such an ectopic calcifying organ in our experiments could be the driving diaphragm. From studying the phenomenon of calciphylaxis, we know that repeated administration of the same challenger that induce calciphylactic calcification after one dose during the so-called critical period can, on the other hand, block the calcifying process. This phenomenon is presumed to represent reversed calciphylaxis.
We have used this experience of reversed calciphylaxis and have administered systemically in repeated doses, a well known calciphylactic challenger, colloidal solution of iron — ferrisaccharate — to 13 of our experimental long-surviving calves. In comparison with untreated animals, we achieved either total or partial prevention of calcification in the majority of treated calves. We presume that the so-called endogenous inhibitors of calcification were stimulated by this treatment. For direct comparison, we examined 13 untreated calves. We also studied the DD in another 40 long-surviving calves and in 12 short surviving animals not treated with iron for up to 30 days of pumping. We assume the systemic factors, i.e., the internal metabolism of calcific promoters and inhibitors as the decisive factors in the calcifying process, whereas the local mechanical and physicochemical factors are so-called supporting, but not decisive, factors.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Whalen RL, Snow JL, Harasaki H, Nosé Y (1980) Mechanical strain and calcification in blood pumps. Trans Am Soc Artif Intern Organs 26: 487–492
Nosé Y, Harasaki H, Murray J (1981) Mineralization of artificial surfaces that contact blood. Trans Am Soc Artif Intern Organs 27: 714–719
Coleman DL (1981) Mineralization of blood pump bladders. Trans Am Soc Artif Intern Organs 27: 708–713
Vašků J, Urbánek P (1995) Electronmicroscopic study of driving diaphragms in the long-term survivals with total artificial heart. Artif Organs 19: 344–354
Harasaki H, Gerrity R, Kiraly R, Jacobs G, Nosé Y (1979) Calcification in blood pumps. Trans Am Soc Artif Intern Organs 25: 305–310
Hughes SD, Coleman DL, Dew PA, Burns GL, Olsen DB, Kolff WJ (1984) Effect of coumadin on thrombus and mineralization in total artificial hearts. Trans Am Soc Artif Intern Organs 30: 75–80
Canezave JF (1989) Interaction of surfaces and blood cells: Platelet reaction. In: Dawids S (ed) Polymers: Their properties and blood compatibility. Kluwer Academic, Dordrecht, pp 49–62
Eloy R, Belleville J (1989) In vivo and in vitro evaluation of blood compatibility. In: Dawids S (ed) Polymers: Their properties and blood compatibility. Kluwer Academic, Dordrecht, pp 287–299
Vašků J (1982) Artificial heart. Pathophysiology of the total artificial heart and of cardiac assist devices. Acta Fac Med Univ Brunensis J.E. Purkyné, Brno, pp 397
Vašků J (1984) Brno experiments in long-term survival with total artificial heart. Acta Fac Med Univ Brunensis J.E. Purkyné, Brno, pp 622
Vašků J, Cerny J, Dostál M, Vašků Jan, Guba P, Petrilka, J, Smutny J, Sotolová O, Doleel S, Vašků A, Masek J (1989) Recent efforts in artificial heart research in Czechoslovakia. Trans Am Soc Artif Intern Organs 35: 805–811
Vašků J, Vaskir Jan, Dostál M, Guba P, Gregor Z, Vašků A, Urbánek P, Cerny J, Doleel S, Cfdl K, Pavlícek V, Bednarik B (1990) Evaluation study of calves with total artificial heart (TAH) surviving for 218–293 days of pumping. Int J Artif Organs 13: 830–836
Vašků J (1989) A contribution to the assessment of pathophysiology in the long-term total artificial heart recipients. In: Unger F (ed) Artificial circulation 3. Springer, Berlin Heidelberg New York Tokyo, pp 340–376
Vašků J (1986) Total artificial heart research in Czechoslovakia: Pathophysiological evaluation of long-term experiments performed from 1979 to 1985. In: Akutsu T (ed) Artificial heart 1. Springer, Tokyo Berlin Heidelberg New York, pp 161–179
Vašků J (1993) Perspectives of total artificial heart research as a valuable modelling system for general physiology and pathophysiology. In: Akutsu T, Koyanagi H (eds) Heart replacement, Artificial heart 4. Springer, Tokyo Berlin Heidelberg New York, pp 161171
Levy RJ, Shoen FJ, Golomb G (1986) Bioprosthetic heart valve calcification. Clinical features, pathobiology and prospects for prevention. CRC Crit Rev Biocompat 2: 147–187
Anderson HC (1981) Normal and abnormal mineralization in mammals. Trans Am Soc Artif Intern Organs, 27: 683–689
Selye H (1962) Calciphylaxis. The University of Chicago Press, Chicago, pp 552
Vašků J (1967) Calciphylaxis, a new biological phenomenon and its importance (in Czech, English summary) State Health Publishing House (Stâtní zdravotnické nakladatelství) Prague (Praha). pp 144
Tzamaloukas AH (1994) Extraosseous calcifications in patients on chronic dialysis. Int J Artif Organs 17: 311–314
Vašků J (1987) Calcification of the driving diaphragm in a total artificial heart. Czechoslovak Medicine 10: 1628
Vašků J (1992) Pathophysiological assessment of a total artificial heart (TAH) in experimental and clinical work. In: Sezai Y (ed) Artificial heart — the development of biomation in the twenty-first century, Nihon University International Symposium. WB Saunders, Tokyo, pp 232–239
Vašků J (1993) The impact of total artificial heart research on the progress in basic medical sciences. In: Sezai Y (ed) Artificial heart — the development of biomation in the twenty-first century, Nihon University International Symposium. Harwood Academic, Chur, pp 9–21
Lian JB, Levy RL, Bernhard W, Szycher M (1981) LVAD mineralization and gamma carboxyglutamic acid containing proteins in normal and pathologically mineralized tissues. Trans Am Soc Artif Intern Organs 27: 683–689
Levy RJ, Shoen FJ, Flowers RB, Staelin ST (1991) Initiation of mineralization in bioprosthetic heart valves: Studies of alkaline phosphatase activity and its inhibition by A1C13 or FeCl3 preincubations. J Biomed Mater Res 25: 905–935
Tomazic BB, Brown WE, Shoen FJ (1994) Physicochemical properties of calcific deposits isolated from porcine bioprosthetic heart valves removed from patients following 2–13 years function. J Biomed Mater Res 28: 35–47
Skalník J, Vašků J, Urbánek E (1970) Calciphylaxis and cerebral atrophy in man. Clin Orthop 69: 172–180
Vašků J, Urbánek E, Wiedermann D, Skalník J (1971) Die Aufgabe des Kalziums in der Pathologie des Bindegewebssystems vom Standpunkt der Kalziphylaxie. Wissensch Ztschr Ernst Moritz Arndt Univ, Greifswald, Math- Naturwissensch Reihe 20: 211–216
Cockerell CJ, Dolan ET (1992) Widespread cutaneous and systemic calcification (calciphylaxis) in patients with the acquired immunodeficiency syndrome and renal disease. J Am Acad Dermatol 26: 559–562
Hollinger JO, Schmitz JP, Yaskovich R, Long MM, Prassad KU, Urry DW (1988) A synthetic polypentapeptide of elastin for initiating calcification. Calcif Tissue Int 42: 231–236
Zartnack F, Dunkel W, Affeld K, Bücherl ES (1978) Fatigue problems in artificial blood pumps. Trans Am Soc Artif Intern Organs 24: 600–605
Cumming RD, Snow JL, Singh PJ, Romero LH, Harpster NK, Lian JB (1985) Mechanical etiology of calcification. In: Watson JT (ed) Proceedings of Devices and technology branch contractors meeting; Division of heart and vascular diseases, National Heart, Lung and Blood Institute. US Department of Health and Human Services, Public Health Service, National Institutes of Health, Bethesda, MD, p 104
Pierce WS, Donachy JH, Rosenberg G (1980) Calcification inside artificial hearts. Inhibition by warfarin sodium. Science 208: 601
Mc Lean FC, Urist MR (1961) Bone — an introduction to the physiology of skeletal tissue. The University of Chicago Press, Chicago, p 260
Vašků J, Urbánek P (1995) Constructional and functional characteristics of recent total artificial heart models TNS BRNO VII, VIII and IX. Artif Organs 19: 535–543
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer Japan
About this paper
Cite this paper
Vašků, J. (1996). Changes in Total Artificial Heart Driving Diaphragms After Long-Term Pumping. In: Akutsu, T., Koyanagi, H. (eds) Heart Replacement. Springer, Tokyo. https://doi.org/10.1007/978-4-431-67020-9_6
Download citation
DOI: https://doi.org/10.1007/978-4-431-67020-9_6
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-67022-3
Online ISBN: 978-4-431-67020-9
eBook Packages: Springer Book Archive